logo

Viewray, Inc. (VRAY)



Trade VRAY now with
  Date
  Headline
10/2/2018 7:31:33 AM ViewRay Appoints James Alecxih As Chief Commercial Officer
8/14/2018 11:05:43 PM ViewRay Announces Pricing Of Underwritten Public Offering Of 16.22 Mln Shares At $9.25/shr
8/14/2018 4:28:50 PM ViewRay Announces Proposed Public Offering Of Common Stock
8/3/2018 7:34:43 AM ViewRay Q2 Loss Per Share $0.30 Vs Loss $0.15 Last Year
7/24/2018 4:32:58 PM ViewRay Appoints Scott Drake As President, CEO And Director
5/10/2018 4:24:28 PM ViewRay Q1 Loss/share $0.11 Vs. Loss $0.54 Year Ago
3/14/2018 8:33:00 AM ViewRay Announces Order For MRIdian MR Image-guided Linac At University Hospital Zurich In Zurich
3/12/2018 7:36:29 AM ViewRay Q4 Net Loss $24.6 Mln Or $0.38 Per Share
2/8/2018 7:38:27 PM B. Riley FBR Starts ViewRay, Inc. (VRAY) At Buy With $13.50 Price Target
11/13/2017 7:03:36 AM ViewRay Q3Total Revenue $12.2 Mln, Up From $0.4 Mln Last Year
6/26/2017 8:38:44 AM National Cancer Center Japan Treats First Patients Using ViewRay MRIdian System
3/16/2017 4:05:56 PM ViewRay Q4 Loss/share $0.25 Vs. Loss $0.37 Year Ago
11/14/2016 7:36:39 AM ViewRay Q3 Net Loss $14.1 Mln Or $0.35/Shr Vs Loss $10.3 Mln Or $0.35/Shr Prior Year
10/13/2016 8:36:23 AM ASTRO Presentations From MRIdian Users Now Available On ViewRay.com
9/19/2016 8:31:37 AM ViewRay Receives CE Mark Approval For Its MRIdian Linac System
9/9/2016 8:31:41 AM ViewRay Gets Chinese Regulatory Approval For MRIdian System